“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

Germany's Innonature - which develops and markets supplements, superfoods and cosmetics for women - has been snapped up by Northern European private-equity firm Verdane.

The latest news from Europe's health, beauty and wellness markets: Nestlé is reducing its stake in L'Oréal to fund an expanded share buyback program; and Stada has opened in office in Sweden to manage the distribution and marketing of a portfolio of well-established Sanofi brands.

NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers  – “is recognized as a consumer-relevant category."

The French beauty giant plans to launch its Colorsonic at-home hair color device with oscillating nozzle in early 2023. L’Oreal showcased the product, along with a breakthrough hair color “reader” and custom mixing system for salon use, at the CES 2022 tech show in Las Vegas.

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

Doubts about Coty’s “viability” have melted away with the return to growth of its Consumer Beauty division and momentum in its burgeoning skin-care and prestige cosmetics businesses. Coty now aims to beat the market with 6% to 8% compound annual revenue growth from fiscal 2022 through 2025.

E.l.f.’s core consumer proposition continues to focus on quality, innovative products at accessible prices, but the company also has been working to strengthen its “clean” credentials, reformulating more than 350 SKUs in recent months to ensure that its namesake brand is “100% clean” by year-end.

Retailer and consumer stockpiling in fear of supply chain disruptions drive double digit consumption growth for Prestige Consumer Healthcare’s Dramamine, Nix, Hydralyte and cough/cold brands. Brands drove total sales up 10.5% excluding impact of Akorn, to $12.4m in latest quarter.